CUSIP 05338F306COM NEWAVTXQ4 2025
46 filings · latest Mar 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bvf Inc/Il | 1.36M | $24.61M |
| 2 | Nantahala Capital Management, LLC | 1.24M | $22.43M |
| 3 | Orbimed Advisors LLC | 1.19M | $21.56M |
| 4 | Affinity Asset Advisors, LLC | 1.05M | $19.09M |
| 5 | Caligan Partners LP | 881.5K | $16.01M |
| 6 | Vanguard Group Inc | 804.1K | $14.60M |
| 7 | Ra Capital Management, L.P. | 663.0K | $12.04M |
| 8 | Millennium Management LLC | 660.0K | $11.99M |
| 9 |
| 4 | Feb 17, 2026 | Ra Capital Management, L.P. | 13G/A | 9.9% | 1.94M | SEC |
| 5 | Feb 17, 2026 | Balyasny Asset Management L.P. | 13G/A | 2.4% | 439.3K | SEC |
| 6 | Feb 17, 2026 | Millennium Management LLC | 13G | 11.0% | 887.3K | SEC |
| 7 | Feb 17, 2026 | Orbimed Advisors LLC | 13G/A | 6.4% | 1.19M | SEC |
| 8 | Feb 17, 2026 | Biotechnology Value Fund L P | 13G/A | 10.0% | 1.90M | SEC |
| 9 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 3.5% | 627.5K | SEC |
| 10 | Feb 10, 2026 | Millennium Management LLC | 13G | 11.0% | 906.8K | SEC |
See the full Schedule 13D/13G history for Avalo Therapeutics Inc.
Unlock full history| Point72 Asset Management, L.P. |
| 627.5K |
| $11.40M |
| 10 | Bank Of America Corp /De/ | 621.4K | $11.28M |